Sequence Similarity Clusters for the Entities in PDB 1LO0

Entity #1 | Chains: L,X
If kappa light chain protein, length: 219 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 3 13640
95 % 1 3 12954 Flexibility: No
Max RMSD: 0.4, Avg RMSD: 0.3
PDBFlex
90 % 51 162 155
70 % 660 2679 1
50 % 1366 5447 1
40 % 1603 6149 1
30 % 1951 7618 1
Entity #2 | Chains: H,Y
Ig gamma 2a heavy chain protein, length: 220 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 3 13639
95 % 1 3 12953 Flexibility: No
Max RMSD: 0.4, Avg RMSD: 0.3
PDBFlex
90 % 1 3 12738
70 % 661 2642 2
50 % 1367 5447 1
40 % 1604 6149 1
30 % 1952 7618 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5YD4 1 A, C, E, G scFv 4B08 10090
17 5YD3 1 A, C, E, G scFv 4B08 10090
18 5UD9 1 H Fab heavy chain 9606
19 5UD9 2 L Light chain 9606
20 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
21 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
22 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
23 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
24 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
25 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
26 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
27 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
28 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
29 6MEE 2 B, D antibody HEPC74 Light Chain 9606
30 6BJZ 1 H 5c8 Fab Heavy chain 9606
31 6BJZ 2 L 5c8 Fab Light chain 9606
32 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
33 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
34 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
35 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
36 4XCF 1 L 4E10 Fab light chain 9606
37 4XCF 2 H 4E10 Fab heavy chain 9606
38 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
39 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
40 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
41 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
42 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
43 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
44 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
45 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
46 5X08 1 H Fab 4E10 Heavy chain 9606
47 5X08 2 L Fab 4E10 Light chain 9606
48 6MEG 1 H antibody HEPC46 Heavy Chain 9606
49 6MEG 2 L antibody HEPC46 Light Chain 9606
50 4XAW 1 L 4E10 Fab light chain 9606
51 4XAW 2 H 4E10 Fab heavy chain 9606
52 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
53 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
54 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
55 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
56 5UCB 1 H Fab Heavy Chain 9606
57 5UCB 2 L Fab Light Chain 9606
58 2VXV 1 H HUMAN IGG ABT-325 9606
59 2VXV 2 L HUMAN IGG ABT-325 9606
60 4GXV 1 H, I Antibody 1F1, heavy chain 9606
61 4GXV 2 L, M Antibody 1F1, light chain 9606
62 2VXT 1 H MURINE IGG 125-2H 10090
63 2VXT 3 L MURINE IGG 125-2H 10090
64 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
65 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
66 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
67 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
68 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
69 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
70 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
71 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
72 5W24 1 L 5C4 Fab Light Chain 10090
73 5W24 2 H 5C4 Fab Heavy Chain 10090
74 4HPY 1 H CH59 Fab heavy chain 9606
75 4HPY 2 L CH59 Fab light chain 9606
76 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
77 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
78 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
79 4JG1 1 L Fab light chain 9606
80 4JG1 2 H Fab heavy chain 9606
81 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
82 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
83 5VF2 1 A scFv 2D10 10090
84 5I8C 1 A VRC34.01 Fab heavy chain 9606
85 5I8C 2 B VRC34.01 Fab light chain 9606
86 4O5L 1 L Fab F045-092 light chain 9606
87 4O5L 2 H Fab F045-092 heavy chain 9606
88 5MYX 1 A, C Fab c#24 light chain 10090
89 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
90 3IFL 1 L 12A11 FAB antibody light chain 10090
91 3IFL 2 H 12A11 FAB antibody heavy chain 10090
92 5WK2 1 L M116 LIGHT CHAIN 9606
93 5WK2 2 H M116 HEAVY CHAIN FD 9606
94 3PP4 1 H GA101 Fab heavy chain 10090
95 3PP4 2 L GA101 Fab light chain 10090
96 3KDM 1 A, L Immunoglobulin light chain 9606
97 3KDM 2 B, H Immunoglobulin heavy chain 9606
98 5NIV 1 A Light chain of 5D3 Fab 10090
99 5NIV 2 B Heavy chain of 5D3 Fab 10090
100 5N4J 1 L LIGHT CHAIN 9606
101 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
102 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
103 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
104 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
105 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
106 5X4G 1 A 6H8 Fab heavy chain 10090
107 5X4G 2 B 6H8 Fab light chain 10090
108 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
109 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
110 4PTU 1 A Antibody pn132p2C05, light chain 9606
111 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
112 4TPR 1 L If kappa light chain 10090
113 4TPR 2 H Fab heavy chain 10090
114 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
115 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
116 3IFN 1 H 12A11 FAB antibody heavy chain 10090
117 3IFN 2 L 12A11 FAB antibody light chain 10090
118 5U3P 1 H DH511.4 Fab Heavy Chain 9606
119 5U3P 2 L DH511.4 Fab Light Chain 9606
120 6BLA 1 H AMM01 Fab Heavy chain 9606
121 6BLA 2 L AMM01 Fab Light chain 9606
122 4TOY 1 H 35O22 Fab Heavy chain 9606
123 4TOY 2 L 35O22 Fab Light chain 9606
124 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
125 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
126 3NPS 2 B S4 FAB HEAVY CHAIN 9606
127 3NPS 3 C S4 FAB LIGHT CHAIN 9606
128 5I4F 1 A scFv 2D10 10090
129 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
130 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
131 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
132 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
133 5WN9 1 H scFv 2D10 9606
134 4XC3 1 L 4E10 Fab light chain 9606
135 4XC3 2 H 4E10 Fab heavy chain 9606
136 4M5Y 1 H, I Fab 5J8 heavy chain 9606
137 4M5Y 2 L, M Fab 5J8 light chain 9606
138 4TQE 1 L If kappa light chain 10090
139 4TQE 2 H Fab heavy chain 10090
140 5YY4 1 A scFv 4B08 10090
141 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
142 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
143 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
144 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
145 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
146 5VSI 2 L CH1/Ckappa Fab light chain 9606
147 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
148 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
149 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
150 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
151 5JXA 1 H VRC03 Heavy chain 9606
152 5JXA 2 L VRC03 Light chain 9606
153 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
154 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
155 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
156 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
157 3NTC 1 L Fab light chain 10090
158 3NTC 2 H Fab heavy chain 10090
159 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
160 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
161 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
162 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
163 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
164 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
165 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
166 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
167 6BE3 1 H Fab (F598) Heavy Chain 9606
168 6BE3 2 L Fab (F598) Light Chain 9606
169 4NWU 1 H APE1551 Ab Fab heavy chain 9606
170 4NWU 2 L APE1551 Ab Fab light chain 9606
171 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
172 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
173 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
174 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
175 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
176 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
177 5EWI 1 H VRC38.01 Heavy Chain 9606
178 5EWI 2 L VRC38.01 Light Chain 9606
179 5E2W 1 L AT8 LIGHT CHAIN 10090
180 5E2W 2 H AT8 HEAVY CHAIN 10090
181 5MYK 1 A Fab c#17 light chain 10090
182 5MYK 2 B Fab c#17 heavy chain 10090
183 4NZR 1 H PGT135 heavy chain Fab 9606
184 4NZR 2 L PGT135 light chain Fab 9606
185 5MYO 1 A, C Fab c#6 light chain 10090
186 5MYO 2 B, D Fab c#6 heavy chain 10090
187 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
188 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
189 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
190 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
191 5UEL 1 H 354NC102 Fab Heavy Chain 9606
192 5UEL 2 L 354NC102 Fab Light Chain 9606
193 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
194 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
195 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
196 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
197 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
198 5E2V 1 L AT8 LIGHT CHAIN 10090
199 5E2V 2 H AT8 HEAVY CHAIN 10090
200 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
201 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
202 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
203 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
204 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
205 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
206 5JUE 1 L light chain of UIC2 Fab 10090
207 5JUE 2 H heavy chain of UIC2 Fab 10090
208 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
209 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
210 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
211 5JR1 1 H 10E8 heavy chain 9606
212 5JR1 2 L 10E8 mature light chain 9606
213 6CA7 1 L PCT64_13C light chain 9606
214 6CA7 2 H PCT64_13C heavy chain 9606
215 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
216 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
217 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
218 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
219 5OB5 2 H fAb Heavy chain 9606
220 5OB5 3 L fAb Light chain 9606
221 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
222 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
223 5I66 1 A 8B6 antibody, heavy chain 10090
224 5I66 2 B 8B6 antibody, light chain 10090
225 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
226 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
227 6BZY 1 H 22D11 Heavy Chain 10090
228 6BZY 2 L 22D11 Light Chain 10090
229 3QQ9 1 C, L 101F LIGHT CHAIN 10090
230 3QQ9 2 D, H 101F HEAVY CHAIN 10090
231 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
232 5TKK 3 L mouse antibody vFP5.01 light chain 10090
233 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
234 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
235 5W6C 1 H UCA Fab heavy chain 9606
236 5W6C 2 L UCA Fab light chain 9606
237 5I1K 1 L FAB LIGHT CHAIN 9606
238 5I1K 2 H FAB HEAVY CHAIN 9606
239 3OZ9 1 L Fab NC-1 kappa light chain 10090
240 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
241 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
242 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
243 5V7U 1 L CBTAU-22.1 Fab light chain 9606
244 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
245 5UEA 1 A, H Fab Heavy Chain 9606
246 5UEA 3 B, L Fab Light Chain 9606
247 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
248 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
249 3G5Y 1 A 175 light chain 10090
250 3G5Y 2 B 175 heavy chain 10090
251 5NMV 1 L Fab light chain 10088
252 5NMV 2 H Fab heavy chain 10088
253 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
254 4N8C 2 L, M Light chain of monoclonal antibody 10090
255 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
256 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
257 4HGW 1 A Antibody Fab fragment, light chain 10090
258 4HGW 2 B Antibody Fab fragment, heavy chain 10090
259 1NLB 1 L antibody 19D9D6 light chain 10090
260 1NLB 2 H antibody 19D9D6 heavy chain 10090
261 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
262 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
263 3VFG 1 L 3F8 Light Chain 10090
264 3VFG 2 H 3F8 Heavy Chain 10090
265 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
266 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
267 3QRG 1 L Fab light chain 9606
268 3QRG 2 H Fab heavy chain Fd fragment 9606
269 5M6A 1 A, B, C, D Bence-Jones light chain 9606
270 4LLY 2 B, D light chain Clambda 9606
271 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
272 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
273 5EZI 1 H Fab c12 heavy chain 9606
274 5EZI 2 L Fab c12 Light chain 9606
275 4K23 1 H anti-uPAR antibody, heavy chain 10090
276 4K23 2 L anti-uPAR antibody, light chain 10090
277 3NCJ 1 L Fab15 Mut8 light chain 9606
278 3NCJ 2 H Fab15 Mut8 heavy chain 9606
279 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
280 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
281 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
282 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
283 5W05 1 L M59 FAB LIGHT CHAIN 10090
284 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
285 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
286 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
287 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
288 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
289 4M61 1 A, C Fab A52 light chain 10090
290 4M61 2 B, D Fab A52 heavy chain 10090
291 5YE3 1 B 2A7D9 VH CH1 chain 10090
292 5YE3 2 A 2A7D9 L chain 10090
293 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
294 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
295 1UM5 1 L Antibody 21H3 L chain 10090
296 1UM5 2 H Antibody 21H3 H chain 10090
297 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
298 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
299 4NWT 1 L APE1531 Ab Fab light chain 9606
300 4NWT 2 H APE1531 Ab Fab heavy chain 9606
301 3WHX 1 A mAb Fab H fragment 10090
302 3WHX 2 B mAb Fab L fragment 10090
303 3NA9 1 L Fab15 light chain 9606
304 3NA9 2 H Fab15 heavy chain 9606
305 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
306 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
307 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
308 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
309 4LRI 1 A, B MSL-109 Light Chain 9606
310 4LRI 2 C, P MSL-109 Heavy Chain 9606
311 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
312 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
313 4JN2 1 A, L anti dabigatran Fab 10090
314 4JN2 2 B, H anti dabigatran Fab 10090
315 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
316 4XBE 2 H 4E10 Fab heavy chain 9606
317 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
318 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
319 6BE2 1 H Fab (F598) Heavy Chain 9606
320 6BE2 2 L Fab (F598) Light Chain 9606
321 4JFZ 1 L Fab light chain 9606
322 4JFZ 2 H Fab heavy chain 9606
323 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
324 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
325 3WIF 1 A mAb Fab H fragment 10090
326 3WIF 2 B mAb Fab L fragment 10090
327 5U6A 1 A Light Chain 9606
328 5U6A 2 B Heavy Chain 9606
329 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
330 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
331 3MBX 1 L X836 LIGHT CHAIN 10090
332 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
333 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
334 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
335 6APC 1 H Epididymis luminal protein 214 9606
336 6APC 2 L IGL@ protein 9606
337 4HHA 1 A Fab KE5 Fab fragment KE5 9606
338 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
339 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
340 4RGO 2 H 14G8 heavy chain Fab 10090
341 4RGO 3 L 14G8 light chain Fab 10090
342 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
343 5GRY 1 A, G diabody 9606
344 5UEK 2 H Fab 12E Heavy Chain 9606
345 5UEK 3 L Fab 12E Light Chain 9606
346 3NAA 1 L Fab15 Mut5 light chain 9606
347 3NAA 2 H Fab15 Mut5 heavy chain 9606
348 1Q0X 1 L Fab 9B1, light chain 10090
349 1Q0X 2 H Fab 9B1, heavy chain 10090
350 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
351 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
352 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
353 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
354 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
355 5IK3 2 B, D 1E03 Fab fragment light chain 9606
356 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
357 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
358 5XLI 1 a, b FabL 10090
359 5XLI 2 c, d FabH 10090
360 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
361 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
362 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
363 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
364 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
365 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
366 4WUK 1 H CH65 heavy chain 9606
367 4WUK 2 L CH65 light chain 9606
368 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
369 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
370 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
371 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
372 5JOP 1 D, L Fab 14.22 light chain 10090
373 5JOP 2 E, H Fab14.22 heavy chain 10090
374 4HPO 1 H CH58 Fab heavy chain 9606
375 4HPO 2 L CH58 Fab light chain 9606
376 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
377 5UKN 2 L DH522UCA Fab fragment light chain 9544
378 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
379 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
380 5IT2 1 H heavy chain 9606
381 5IT2 2 L light chain 9606
382 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
383 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
384 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
385 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
386 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
387 5MO3 3 L Fab of monoclonal antibody, light chain 10090
388 5GZ0 1 A, C FM329 light chain 1383439
389 5GZ0 2 B, D FM329 heavy chain 1383439
390 6DW2 1 A 6078 Fab light chain 9606
391 6DW2 2 B 6078 Fab heavy chain 9606
392 6BQB 1 L MGG4 Fab light chain 9606
393 6BQB 2 H MGG4 Fab heavy chain 9606
394 4PUB 1 H DX-2930 HEAVY CHAIN 9606
395 4PUB 2 L DX-2930 LIGHT CHAIN 9606
396 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
397 6B14 2 L Light chain of Fab BL3-6S97N 10090
398 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
399 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
400 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
401 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
402 5GS3 1 A, H diabody protein 9606
403 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
404 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
405 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
406 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
407 5VKD 2 H Fab Heavy Chain 9606
408 5VKD 3 L Fab light chain 9606
409 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
410 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
411 5XHG 1 A, C polypeptide(L) 10090
412 5XHG 2 B, D polypeptide(H) 10090
413 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
414 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
415 3UYR 1 H antibody Fab heavy chain 10090
416 3UYR 2 L antibody Fab light chain 10090
417 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
418 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
419 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
420 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
421 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
422 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
423 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
424 3OAZ 2 K, L Fab 2G12, light chain 9606
425 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
426 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
427 1ZAN 1 L Fab AD11 Light Chain 10116
428 1ZAN 2 H Fab AD11 Heavy Chain 10116
429 6CJK 1 A, C Immunoglobulin Fab light chain 9986
430 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
431 4N0Y 1 H IGH526 Heavy Chain 9606
432 4N0Y 2 L IGH526 Light Chain 9606
433 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
434 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
435 5MTH 1 A, H antibody Fab heavy chain 10090
436 5MTH 2 B, L antibody Fab light chain 10090
437 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
438 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
439 1RZF 1 L Fab E51 light chain 9606
440 1RZF 2 H Fab E51 heavy chain 9606
441 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
442 4KTE 2 L GE148 Light Chain Fab 9544
443 5I8O 1 H HMM5 antibody heavy chain 9606
444 5I8O 2 L HMM5 antibody light chain 9606
445 4JG0 1 L Fab light chain 9606
446 4JG0 2 H Fab heavy chain 9606
447 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
448 4YGV 2 B, L aDabi-Fab2a light chain 9606
449 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
450 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
451 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
452 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
453 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
454 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
455 3EO0 1 A, C GC-1008 Fab Light Chain 10090
456 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
457 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
458 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
459 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
460 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
461 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
462 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
463 4FQI 3 H antibody CR9114 heavy chain Fab 9606
464 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
465 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
466 4JHA 2 L D25 light chain 9606
467 6B9Z 1 A Trastuzumab Fab light chain 10090
468 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
469 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
470 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
471 4PTT 1 A Antibody pn132p2C05, light chain 9606
472 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
473 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
474 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
475 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
476 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
477 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
478 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
479 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
480 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
481 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
482 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
483 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
484 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
485 4DGV 1 H HCV1 Heavy Chain Fab 9606
486 4DGV 2 L HCV1 Light Chain 9606
487 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
488 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
489 5TH2 1 A, C cetuximab Fab, light chain 10090
490 5TH2 2 B, D cetuximab Fab, heavy chain 10090
491 5I8K 1 L HHH1 Fab Light chain 9606
492 5I8K 2 H HHH1 Fab Heavy chain 9606
493 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
494 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
495 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
496 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
497 1YNL 1 L Ig gamma light chain 10090
498 1YNL 2 H Ig gamma heavy chain 10090
499 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
500 5EPM 2 B, F Antibody Fab fragment light chain 10090
501 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
502 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
503 3UMT 1 A scFv heavy chain and light chain 10090
504 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
505 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
506 4NUJ 1 A PGT152 light chain 9606
507 4NUJ 2 B PGT152 heavy chain 9606
508 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
509 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
510 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
511 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
512 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
513 3U2S 2 B, L PG9 light chain 9606
514 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
515 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
516 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
517 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
518 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
519 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
520 4NUG 1 L PGT151 light chain 9606
521 4NUG 2 H PGT151 heavy chain 9606
522 3IU4 1 H chP3 Fab heavy chain 10090
523 3IU4 2 L chP3 Fab light chain 10090
524 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
525 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
526 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
527 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
528 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
529 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
530 1P7K 1 A, L antibody light chain FAB 10090
531 1P7K 2 B, H antibody heavy chain FAB 10090
532 3RVV 2 C 4C1 - light chain 10090
533 3RVV 3 D 4C1 - heavy chain 10090
534 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
535 3P0Y 2 H Fab DL11 heavy chain 9606
536 3P0Y 3 L Fab DL11 light chain 9606
537 4NPY 1 A, L germline PGT121 light chain Fab 9606
538 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
539 6ANA 2 H LL2 Fab Heavy Chain 10090
540 6ANA 3 L LL2 Fab Light Chain 10090
541 5IBU 1 B, L 6652 Light Chain 9606
542 5IBU 2 G, H 6652 Heavy Chain 9606
543 5VPL 2 C 4C1 - LIGHT CHAIN 10090
544 5VPL 3 D 4C1 - HEAVY CHAIN 10090
545 6AOD 1 A FXIa Antibody FAB Light Chain 9606
546 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
547 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
548 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
549 2YPV 2 H FAB 12C1 10090
550 2YPV 3 L FAB 12C1 10090
551 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
552 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
553 4JY5 1 L PGT122 light chain Fab 9606
554 4JY5 2 H PGT122 heavy chain Fab 9606
555 6ELE 1 A, H fAB heavy chain 9606
556 6ELE 2 B, L fAB light chain 9606
557 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
558 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
559 6B5R 1 H CIS42 Fab Heavy chain 9606
560 6B5R 2 L CIS42 Fab Light chain 9606
561 3NAC 1 L Fab15 Mut7 light chain 9606
562 3NAC 2 H Fab15 Mut7 heavy chain 9606
563 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
564 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
565 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
566 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
567 1Q72 1 L Fab M82G2, Light chain 10090
568 1Q72 2 H Fab M82G2, Heavy chain 10090
569 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
570 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
571 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
572 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
573 4YHO 1 H aDabi-Fab3 heavy chain 9606
574 4YHO 2 L aDabi-Fab3 light chain 9606
575 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
576 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
577 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
578 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
579 4DGY 1 H HCV1 Heavy Chain Fab 9606
580 4DGY 2 L HCV1 Light Chain 9606
581 5EN2 1 A GD01 heavy chain 10090
582 5EN2 2 B GD01 light chain 10090
583 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
584 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
585 3MXW 2 L 5E1 light chain 9606
586 3MXW 3 H 5E1 heavy chain 9606
587 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
588 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
589 3EO9 1 L Efalizumab Fab fragment, light chain 9606
590 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
591 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
592 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
593 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
594 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
595 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
596 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
597 5WUV 1 L light chain 9606
598 5WUV 2 H heavy chain 9606
599 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
600 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
601 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
602 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
603 4JM4 1 H PGT 135 Heavy Chain Fab 9606
604 4JM4 2 L PGT 135 Light Chain Fab 9606
605 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
606 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
607 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
608 5YE4 2 B, D 1A9D7 L chain 10090
609 6B0G 1 C 1245 Antibody, Light Chain 9606
610 6B0G 2 D 1245 Antibody, Heavy Chain 9606
611 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
612 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
613 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
614 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
615 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
616 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
617 6D0X 1 A 2140 Antibody, heavy chain 9606
618 6D0X 2 B 1210 Antibody, light chain 9606
619 6BE4 1 H Fab (F598) Heavy Chain 9606
620 6BE4 2 L Fab(F598) Light Chain 9606
621 5TPP 1 L DH270.5 Fab heavy chain 9606
622 5TPP 2 H DH270.5 Fab light chain 9606
623 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
624 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
625 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
626 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
627 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
628 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
629 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
630 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
631 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
632 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
633 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
634 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
635 5TL5 1 L M2177 LIGHT CHAIN 10090
636 5TL5 2 H M2177 HEAVY CHAIN 10090
637 2FX7 1 L Fab 4E10 Light Chain 9606
638 2FX7 2 H Fab 4E10 Heavy Chain 9606
639 5Y9K 1 L belimumab light chain 9606
640 5Y9K 2 H belimumab heavy chain 9606
641 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
642 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
643 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
644 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
645 3WFH 1 A mAb Fab H fragment 10090
646 3WFH 2 B mAb Fab L fragment 10090
647 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
648 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
649 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
650 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
651 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
652 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
653 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
654 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
655 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
656 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
657 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
658 5HI4 3 D, L CAT-2000 FAB light chain 9606
659 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
660 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
661 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
662 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
663 3RVW 2 C 4C1 - light chain 10090
664 3RVW 3 D 4C1 - heavy chain 10090
665 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
666 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
667 5XKU 2 B HNIgGA6 light chain 9606
668 5XKU 3 C HNIgGA6 heavy chain 9606
669 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
670 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
671 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
672 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
673 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
674 5HI5 3 D, L CAT-2000 light chain 9606
675 5JO5 1 A, C, E, H 10E8 gHV 9606
676 5JO5 2 B, D, F, L 10E8 gLV 9606
677 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
678 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
679 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
680 5CCK 2 L Antibody 3BC315 Fab light chain 9606
681 5I76 1 A, C FM318_light_chain 1383439
682 5I76 2 B, D FM318_heavy_cahin 1383439
683 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
684 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
685 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
686 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
687 5I18 1 L FAB LIGHT CHAIN 9606
688 5I18 2 H FAB HEAVY CHAIN 9606
689 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
690 4JN1 2 L anti-dabigatran Fab1, light chain 10090
691 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
692 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
693 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
694 4G5Z 2 L canakinumab antibody fragment light chain 9606
695 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
696 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
697 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
698 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
699 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
700 2OK0 2 L Fab ED10 light chain 10090
701 2OK0 3 H Fab ED10 heavy chain 10090
702 3SOB 1 L antibody light chain 9606
703 3SOB 3 H antibody heavy chain 9606
704 6B5M 1 H CIS43 Fab Heavy chain 9606
705 6B5M 2 L CIS43 Fab Light chain 9606
706 5AWN 1 H Heavy chain of 3BC176 Fab 9606
707 5AWN 2 L Light chain of 3BC176 Fab 9606
708 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
709 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
710 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
711 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
712 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
713 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
714 5DR5 2 L AbD09097 Fab light chain 9606
715 2IH3 1 A FAB Heavy Chain 10090
716 2IH3 2 B FAB Light Chain 10090
717 4KQ3 1 L CNTO3186 light chain Fab 9606
718 4KQ3 2 H CNTO3186 heavy chain Fab 9606
719 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
720 6AQ7 3 L POM6 FAB light CHAIN 10090
721 4JFX 1 A, L Fab light chain 9606
722 4JFX 2 B, H Fab heavy chain 9606
723 3SGE 1 I, L Light Chain 10090
724 3SGE 2 H, J Heavy Chain 10090
725 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
726 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
727 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
728 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
729 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
730 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
731 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
732 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
733 5FHB 1 H Antibody 100 Fab heavy chain 9606
734 5FHB 2 L Antibody 100 Fab light chain 9606
735 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
736 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
737 1JGU 1 L Antibody Light Chain 10090
738 1JGU 2 H Antibody Heavy Chain 10090
739 4I77 1 H Lebrikizumab heavy chain Fab 9606
740 4I77 2 L Lebrikizumab light chain Fab 9606
741 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
742 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
743 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
744 4O4Y 2 H 2095-2 heavy chain 9986
745 5OBF 1 H fAb Heavy chain 10090
746 5OBF 2 L fAb Light chain 10090
747 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
748 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
749 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
750 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
751 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
752 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
753 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
754 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
755 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
756 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
757 5MHE 1 L Fab-fragment 10090
758 5MHE 2 H Fab-fragment 10090
759 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
760 4GLR 3 I, K anti-ptau light chain light chain 9031
761 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
762 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
763 4HJG 1 A Trastuzumab light chain 9606
764 4HJG 2 B Trastuzumab heavy chain 9606
765 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
766 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
767 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
768 5I30 1 L Fab PL-2 light chain 10090
769 5I30 2 H Fab PL-2 heavy chain 10090
770 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
771 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
772 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
773 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
774 3FN0 1 L Fab Z13e1 light chain 9606
775 3FN0 2 H Fab Z13e1 heavy chain 9606
776 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
777 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
778 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
779 4YHI 2 B, L aDabi-Fab2a light chain 9606
780 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
781 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
782 4OSU 1 H SM5-1 Fab Heavy Chain 9606
783 4OSU 2 L SM5-1 Fab Light Chain 9606
784 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
785 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
786 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
787 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
788 1T2Q 1 L Fab NNA7 Heavy Chain 10090
789 1T2Q 2 H Fab NNA7 Light Chain 10090
790 6ELJ 1 A, H fAB heavy chain 9606
791 6ELJ 2 B, L fAB light chain 9606
792 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
793 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
794 4MAU 1 L C2244 light chain SEE REMARK 999 10090
795 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
796 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
797 3LEX 2 B, L 11f10 Antibody Light Chain 10090
798 6B0W 1 L 1710 antibody, light chain 9606
799 6B0W 2 H 1710 antibody, heavy chain 9606
800 1OP3 1 K, L FAB 2G12, light chain light chain 9606
801 1OP3 2 H, M FAB 2G12, heavy chain heavy chain 9606
802 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
803 5VH4 2 B, L Infliximab Fab Light Chain 10090
804 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
805 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
806 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
807 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
808 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
809 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
810 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
811 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
812 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
813 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
814 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5 10090
815 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
816 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090
817 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090
818 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090
819 3S96 1 A, C 3B5H10 FAB heavy chain 10090
820 3S96 2 B, D 3B5H10 FAB light chain 10090
821 4LKX 1 A Fab fragment heavy chain 9606
822 4LKX 2 B Fab fragment light chain 9606
823 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
824 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
825 3SE8 2 H Heavy chain of antibody VRC03 Antigen binding fragement of antibody heavy chain 9606
826 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606
827 5JW5 1 A, H MEDI8852 Heavy chain 9606
828 5JW5 2 B, L MEDI8852 Light chain 9606
829 5VH3 1 A, H Infliximab Fab Heavy Chain 10090
830 5VH3 2 B, L Infliximab Fab Light Chain 10090
831 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
832 6DCV 2 B, H heavy chain of CBTAU-27.1 Fab 9606
833 5HDQ 2 H Fab Heavy Chain 10090
834 5HDQ 3 L Fab Light Chain 10090
835 4FQ2 1 H Fab heavy chain 9606
836 4FQ2 2 L Fab light chain 9606
837 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090
838 3RKD 3 D, H Monoclonal Antibody, Heavy Chain 10090
839 3L1O 1 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 H CHAIN 10090
840 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090
841 2A77 1 L Immunoglobulin Light Chain 10090
842 2A77 2 H Immunoglobulin Heavy Chain 10090
843 2FB4 1 L IGG1-LAMBDA KOL FAB (LIGHT CHAIN) 9606
844 2FB4 2 H IGG1-LAMBDA KOL FAB (HEAVY CHAIN) 9606
845 3GO1 1 L Fab 268-D, light chain 9606
846 3GO1 2 H Fab 268-D, heavy chain 9606
847 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090
848 1F3D 2 H, K CATALYTIC ANTIBODY 4B2 HEAVY CHAIN - FAB FRAGMENT 10090
849 3QWO 1 B, L motavizumab light chain 10090
850 3QWO 2 A, H motavizumab heavy chain 10090
851 3CVI 1 H 25-D1.16 Heavy chain 10090
852 3CVI 2 L 25-D1.16 Light chain 10090
853 1PZ5 1 A Light chain of Fab (SYA/J6) 10090
854 1PZ5 2 B Heavy chain of Fab (SYA/J6) 10090
855 1LK3 2 L, M 9D7 Light Chain Fab fragment, Residues 1-210 10116
856 1LK3 3 H, I 9D7 Heavy Chain Fab fragment, Residues 1-219 10116
857 4IOI 1 A Trastuzumab light chain 9606
858 4IOI 2 B Trastuzumab heavy chain 9606
859 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090
860 1N7M 2 L Germline Metal Chelatase Catalytic Antibody, chain L 10090
861 4OKV 1 A, C heavy chain of 8H7 mAb 10090
862 4OKV 2 B, D light chain of 8H7 mAb 10090
863 6GHG 1 A, H Fab heavy chain 9606
864 6GHG 2 B, L Fab light chain 9606
865 6B5S 1 H CIS42 Fab Heavy chain 9606
866 6B5S 2 L CIS42 Fab Light chain 9606
867 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
868 5K8A 2 B, F, H, V Heavy chain 10090
869 5WKZ 1 H Immunoglobulin heavy variable 1-69D,IgG H chain 9606
870 5WKZ 2 L Lambda-chain (AA -20 to 215) 9606
871 1JGV 1 L Antibody Light Chain 10090
872 1JGV 2 H Antibody Heavy Chain 10090
873 5VAG 2 B Light chain of antibody m826 9606
874 5VAG 3 C Heavy chain of antibody m826 9606
875 3MLX 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
876 3MLX 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
877 3I9G 1 H Sonepcizumab antibody Fab fragment, heavy chain Fab Fragment 10090
878 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090
879 5GIR 1 A, H Heavy chain of Fab fragment 10090
880 5GIR 2 B, L Light chain of Fab fragment 10090
881 2ADF 2 H 82D6A3 IgG FAB 10090
882 2ADF 3 L 82D6A3 IgG FAB 10090
883 5I16 1 A, L FAB LIGHT CHAIN 9606
884 5I16 2 B, H FAB HEAVY CHAIN 9606
885 3O41 1 B, L Mouse monoclonal antibody 101F Fab light chain 10090
886 3O41 2 A, H Mouse monoclonal antibody 101F Fab heavy chain 10090
887 5F9O 2 H CH235.9 Heavy chain 9606
888 5F9O 3 L CH235.09 Light chain 9606
889 3Q6G 1 L, M Light chain of Fab of rhesus mAb 2.5B 9544
890 3Q6G 2 H, I Heavy chain of Fab of rhesus mAb 2.5B 9544
891 1UM4 1 L Antibody 21H3 L chain 10090
892 1UM4 2 H Antibody 21H3 H chain 10090
893 5VJQ 1 A, C, E, G HyHEL10 heavy chain Fab fragment carrying three mutations; I29F, S52T, Y53F DEL-I 10090 3.2.1.18 | Details
894 5VJQ 2 B, D, F, H HyHEL10 light chain Fab fragment 10090
895 4RBP 1 K, L Fab 2G12 light chain 9606
896 4RBP 2 H, M Fab 2G12 heavy chain 9606
897 3I75 1 A Antibody heavy chain 10090
898 3I75 2 B Antibody light chain 10090
899 4XVS 1 H VRC07_1995 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Heavy chain 9606
900 4XVS 2 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Light chain 9606
901 7FAB 1 L IGG1-LAMBDA NEW FAB (LIGHT CHAIN) 9606
902 7FAB 2 H IGG1-LAMBDA NEW FAB (HEAVY CHAIN) 9606
903 4FQL 1 H monoclonal antibody CR8033 heavy chain Fab 9606
904 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606
905 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
906 1NGX 2 B, H Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
907 1E6O 1 H IMMUNOGLOBULIN HEAVY CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') HEAVY CHAIN 1-219 10090
908 1E6O 2 L IMMUNOGLOBULIN LIGHT CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') LIGHT CHAIN 1-210 10090
909 5GIS 1 H Heavy chain of Fab fragment 10090
910 5GIS 2 L Light chain of Fab fragment 10090
911 1JFQ 1 L ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY LIGHT CHAIN 10090
912 1JFQ 2 H ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY HEAVY CHAIN 10090
913 6B0S 1 H 1710 antibody, heavy chain 9606
914 6B0S 2 L 1710 antibody, light chain 9606
915 5FGC 2 B Anti-HCV E2 Fab HC33.8 light chain 9606
916 5FGC 3 E Anti-HCV E2 Fab HC33.8 heavy chain 9606
917 5GRX 1 G, H diabody protein 9606
918 6DCW 1 L Light chain of CBTAU27.1 Fab 9606
919 6DCW 2 H Heavy chain of CBTAU27.1 Fab 9606
920 6DB6 1 H Human monoclonal anti-HIV-1 gp120 V3 antibody 311-11D Fab heavy chain 9606
921 6DB6 2 L Human monoclonal anti-HIV-1 gp120 V3 antibody 311-11D Fab light chain 9606
922 4H20 1 L Light chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090
923 4H20 2 H Heavy chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090
924 5GGQ 1 L nivolumab light chain 9606
925 5GGQ 2 H nivolumab heavy chain 9606
926 4RFE 1 A, C, E, H Fab heavy chain of ADCC-potent anti-HIV-1 antibody JR4 9544
927 4RFE 2 B, D, F, L Fab light chain of ADCC-potent anti-HIV-1 antibody JR4 9544
928 6B5N 1 H CIS43 Fab Heavy chain 9606
929 6B5N 2 L CIS43 Fab Light chain 9606
930 3OAY 1 K, L Fab 2G12, light chain 9606
931 3OAY 2 H, M Fab 2G12, heavy chain 9606
932 1CR9 1 L FAB ANTIBODY LIGHT CHAIN HEAVY CHAIN 10090
933 1CR9 2 H FAB ANTIBODY HEAVY CHAIN LIGHT CHAIN 10090
934 6AND 2 H Pinatuzumab Fab Heavy chain 9606
935 6AND 3 L Pinatuzumab Fab light chain 9606
936 1A3L 1 L IMMUNOGLOBULIN FAB 13G5 (LIGHT CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090
937 1A3L 2 H IMMUNOGLOBULIN FAB 13G5 (HEAVY CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090
938 5W0D 2 B Lineage K03.12 UCA antibody heavy chain 9606
939 5W0D 3 C Lineage K03.12 UCA antibody light chain 9606
940